Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Tenax Therapeutics Inc
TENX | US
11.02
USD0.33
3.09%
TENX | US
Loading StockChartView...
About Tenax Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
11.02
Open
10.63
High
11.82
Low
10.37
Tenax Therapeutics Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension. It develops TNX-101 (IV) TNX-102 and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib) a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics Inc. and changed its name to Tenax Therapeutics Inc. in September 2014. Tenax Therapeutics Inc. was founded in 1967 and is based in Chapel Hill North Carolina.
View LessTENX | US
Risk
55.8
Sharpe
1.42
Luna's Score
60/100
Recommendation
Hold
Luna says (TENX | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
73.8%1 month
55.8%3 months
86.8%6 months
70.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
0.30
Price to book
1.50
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-0.14
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-13.03M
MarketCap
37.57M
MarketCap(USD)
37.57M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-113.79
Short ratio
0.95
Short perc.
1.13
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.48
Range1M
3.71
Range3M
8.98
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.56
Price X volume
5.86M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.14 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.50 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 86.79 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.03 | 0.25 | Cheaper |
| Market Cap | 37.57M | 3.66B | Emerging |
